Ischemic stroke is one of major cause of mortality and disability in Indonesia. Stem Cells are considered as a promising therapy for ischemic stroke. In this study, we compared therapeutic potency of Stem cell from human exfoliated deciduous teeth (SHED) and Human umbilical cord blood mononuclear cell (cbMNC) using rat models of ischemic stroke. Following middle cerebral artery occlusion (MCAO), twenty male wistar rats were divided into four groups : normal rats (n=5), rats undergone permanent MCAO (n=5) as the control (stroke) group, rats undergone permanent MCAO and SHED transplantation (n=5) and rats undergone permanent MCAO and cbMNC transplantation (n=5) as the treatment group. SHED transplantation was performed at the acute phase after MCAO by intravenous injection. Histopathological evaluation of the neuron death ratio with hematoxylin and eosin staining confirmed that there was no significant differences at comparative study of neuron death ratio in rats transplanted with SHED and rats transplanted with cbMNC (p=0,81). SHED and cbMNC transplantation at acute stroke showed reduction in the neuron death ratio in the brain of rat models with ischemic stroke, and may provide an opportunity for neuroprotection and neural regeneration after ischemic stroke.
INTRODUCTION
Ischemic stroke is one of major cause of mortality and disability worldwide, particularly in Indonesia (Johnson, 2016; RISKESDAS, 2013) . The incidence of stroke is increasing, and over the last four decades, the incidence was doubled in low-and middle-income countries, and mainly affect individuals at their productive age (Johnson, 2016) .
The prevalence of stroke in Indonesia in 2013 is 12,1 per 1000 population according to basic medical
Research (RISKESDAS) (RISKESDAS, 2013).
The increasing number and the burden caused by stroke makes the need for effective therapy for neurorestoration and neural regeneration after ischemic stroke. Stem cell transplantation may provide a promising opportunity for its neuroprotective effects and its potential for replacing the damaged neurons after ischemic stroke, thus enhancing neurological outcomes (Wei et al., 2013) .
Stem cell from human deciduous teeth (SHED) are mesenchimal stem cells, which extracted from the pulp of exfoliated deciduous teeth (Rossa et al., 2016) . Previous studies suggested that SHED has potential to differentiate into neurons in vitro, and has a high proliferation capability.
SHED also suggested have paracrine effects such as facilitated the differentiation of endogen stem cells. SHED can secrete neurotrophic factors that enhance neurogenesis and angiogenesis after ischemic stroke. SHED also applicable for autologous tissue regeneration without the risk of immune reactions. SHED extraction is less invasive, and it is superior for their easy isolation, expansion, storage, and raise less ethical issues than other stem cell sources (Mita et al., 2015; Wei et al., 2013) .
While Human umbilical cord blood mononuclear cell (cbMNC) is also a potential source for cell-based therapy for ischemic stroke. cbMNC proved to have contribution to neurogenesis and angiogenesis after ischemic stroke (Fruchtman et al., 2004) . From previous studies, cbMNC proved can decrease apoptosis, reduce inflammation in periinfarct area, and stimulate angiogenesis, so that it can improve functional recovery when transplanted to rat models of ischemic stroke (Fruchtman et al., 2004; Ringden et al., 2008) .
This research was conducted to compare therapeutic potency of Stem cell from human exfoliated deciduous teeth (SHED) and Human umbilical cord blood mononuclear cell (cbMNC) using rat models of ischemic stroke. In this study, we investigate whether intravenous administration of SHED and cbMNC can reduce neuronal death in the infarcted area of brain after ischemic stroke. The aim of this study is to provide optimal therapy for ischemic stroke.
METHODS
This is a clinical trial using a prospective interventional approach on SHED and cbMNC transplantation in animal models (Wistar rats) with ischemic stroke. Twenty male wistar rats were divided into four groups : normal rats (n=5), rats undergone permanent MCAO (n=5) as the control The calculation conducted at the brain cortex area, in five visual areas, with a consisten location.
RESULTS
Histopathological evaluation of the neuron death ratio with hematoxylin and eosin staining confirmed that there were significant differences of neuron death ratio in Stroke+SHED group compared to stroke group (p<0,001) at 21 days after MCAO. 
DISCUSSION
Our study demonstrated that both SHED and cbMNC transplantation reduced neuron death ratio in the acute phase in animal model of ischemic stroke.
The comparative study of neuron death ratio in rats transplanted with SHED and cbMNC confirmed no significant differences, indicated that SHED and cbMNC transplantation effect were similar for neuronal death reduction after ischemic stroke. outcome on ischemic rats brain (Yamagata et al., 2013 
